Response Biomedical
Response develops, manufactures and markets diagnostic tests on RAMP Platform.
Business Model:
Revenue: $5.3M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Response Biomedical Information
Response Biomedical was acquired by
OrbiMed.
The acquisition happend on 2016-06-17.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1781 – 75th Avenue W.
City: Vancouver
State: british columbia
Zip: V6P 6P2
Country: CA
Financial Info
Stage:
post ipo debt
Raised Last:
$3M
Raised Total:$20M
Social
Metrics
5,256,271Website Global Rank
1,730Website Monthly Traffic
Twitter Followers
Description
Response develops, manufactures and markets diagnostic tests on RAMP Platform.
Contact Phone:
+16044566010
Contact Email:
Response Biomedical went public on 12/1/2003 on the TMX Group - Toronto Stock Exchange
Listed Exchange:
TMX Group - Toronto Stock Exchange
IPO Date:
12/1/2003
Ticker Symbol:
RBM
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2009 | Equity | $3.9M | 9/2013 | Equity | $3.1M | 12/2011 | Equity | $4.9M | 10/2013 | Post-IPO Equity | $3.1M | 1/2012 | Post-IPO Equity | $4.9M | 8/2010 | Post-IPO Equity | $7.7M | 5/2009 | Post-IPO Equity | $3.1M | 2/2014 | Post-IPO Debt | 1 | $2.5M |
Silicon Valley Bank Silicon Valley Bank |
7/2010 | Equity | $7.7M | 11/2011 | Debt | $265.2k | 12/2011 | Post-IPO Debt | $265.2k |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
